• After the Covid pandemic, we have resumed stem cell treatments. Appropriate sterility and great care in sanitisation is undertaken as usual. If you are unwell with a cough cold or respiratory symptoms it is best to postpone your procedure.

Neurology Library

Stem cell-based therapy for Parkinson’s disease.

 150 150 NZ Stem Cell Treatment Centre

Ann Med. 2005; 37(7) : 487-98. Stem cell-based therapy for Parkinson’s disease. Correia AS, Anisimov SV, Li JY, Brundin P. Neuronal Survival Unit, Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund University, Lund, Sweden. Sofia.Correia@med.lu.se Abstract Motor dysfunctions in Parkinson’s disease are considered to be primarily due to the degeneration of dopaminergic neurons in…

read more

Stem cell treatment for Parkinson’s disease: an update for 2005.

 150 150 NZ Stem Cell Treatment Centre

Curr Opin Neurol. 2005 Aug; 18(4) : 376-85. Stem cell treatment for Parkinson’s disease: an update for 2005. Snyder BJ, Olanow CW. Department of Neurosurgery, Mount Sinai School of Medicine, New York, NY 10029, USA. Abstract PURPOSE OF REVIEW: The hallmark pathologic feature of Parkinson’s disease is loss of melanized dopaminergic neurons within the substantia…

read more

Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment.

 150 150 NZ Stem Cell Treatment Centre

Autoimmune Dis. 2010 Dec 15;2011:164608. Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment. Witherick J, Wilkins A, Scolding N, Kemp K. Multiple Sclerosis and Stem Cell Group, Institute of Clinical Neurosciences, School of Clinical Sciences, University of Bristol, Bristol BS16 1LE, UK. Abstract Although significant advances have recently been…

read more

Why should mesenchymal stem cells (MSCs) cure autoimmune diseases?

 150 150 NZ Stem Cell Treatment Centre

Curr Opin Immunol. 2010 Dec;22(6):768-74. Epub 2010 Nov 17. Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Uccelli A, Prockop DJ. Department of Neurosciences Ophthalmology and Genetics, University of Genoa, Italy. auccelli@neurologia.unige.it Abstract The adult stem/progenitor cells from bone marrow and other tissues referred to as mesenchymal stem cells or multipotent mesenchymal stromal cells…

read more

Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells.

 150 150 NZ Stem Cell Treatment Centre

Stem Cell Rev. 2010 Dec; 6(4) : 548-59 Inflammatory cytokine induced regulation of superoxide dismutase 3 expression by human mesenchymal stem cells. Kemp K, Gray E, Mallam E, Scolding N, Wilkins A Abstract Increasing evidence suggests that bone marrow derived-mesenchymal stem cells (MSCs) have neuroprotective properties and a major mechanism of action is through their…

read more

A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it’s time!

 150 150 NZ Stem Cell Treatment Centre

2010 Dec;6(4):500-6. A consensus statement addressing mesenchymal stem cell transplantation for multiple sclerosis: it’s time! Siatskas C, Payne NL, Short MA, Bernard CC. Monash immunology and stem cell laboratories, Monash University, Clayton, Victoria, 3800, Australia. christopher.siatskas@monash.edu Abstract Multiple sclerosis is a neurodegenerative disease of the central nervous system that is characterized by inflammation, demyelination with…

read more

Stem cells as therapeutics for neurodegenerative disorders?

 150 150 NZ Stem Cell Treatment Centre

Stem cells as therapeutics for neurodegenerative disorders? Mattson MP. Laboratory of Neurosciences, National Institute on Aging GRC 4F01, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA. mattsonm@grc.nia.nih.gov Abstract Aging is associated with a progressive increase in the risk of several prominent neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, stroke and amyotrophic lateral sclerosis.…

read more

Mesenchymal Stem Cells for Multiple Sclerosis: Does Neural Differentiation Really Matter?

 150 150 NZ Stem Cell Treatment Centre

Curr Stem Cell Res Ther. 2010 Oct 18. [Epub ahead of print] Mesenchymal Stem Cells for Multiple Sclerosis: Does Neural Differentiation Really Matter? Uccelli A, Morando S, Bonanno S, Bonanni I, Leonardi A, Mancardi G. Department of Neurosciences, Ophthalmology and Genetics, University of Genoa, Genoa. auccelli@neurologia.unige.it Abstract The lack of therapies fostering remyelination and regeneration…

read more

Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study.

 150 150 NZ Stem Cell Treatment Centre

J Neuroimmunol. 2010 Oct 8; 227(1-2) : 185-9. Epub 2010 Aug 21. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. Yamout B, Hourani R, Salti H, Barada W, El-Hajj T, Al-Kutoubi A, Herlopian A, Baz EK, Mahfouz R, Khalil-Hamdan R, Kreidieh NM, El-Sabban M, Bazarbachi A. Departments of Internal…

read more

Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population.

 150 150 NZ Stem Cell Treatment Centre

Ann Hematol. 2010 Sep 25; Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population. Xu J, Ji BX, Su L, Dong HQ, Sun WL, Wan SG, Liu YO, Zhang P, Liu CY Abstract To evaluate clinical outcomes of autologous peripheral blood…

read more